Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Cited by (1,018)

Items 501–600 of 1,018

1. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species
   Pfaller, M.A., Rhomberg, P.R., Messer, S.A., Castanheira, M. · 2015 · Diagnostic Microbiology and Infectious Disease
2. Positions and Numbers of <i>FKS</i> Mutations in Candida albicans Selectively Influence <i>In Vitro</i> and <i>In Vivo</i> Susceptibilities to Echinocandin Treatment
   Lackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., Lass-Flörl, C. · 2014 · Antimicrobial Agents and Chemotherapy
3. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects
   Karin R. Engelhardt, Bodo Grimbacher · 2012 · Journal of Allergy and Clinical Immunology
4. Nystatin Effectiveness in Oral Candidiasis Treatment: A Systematic Review & Meta-Analysis of Clinical Trials
   Anamika Rai, Satya Ranjan Misra, Saurav Panda, Grzegorz Sokolowski, Lora Mishra, Rupsa Das, Barbara Łapińska · 2022 · Life
5. Epidemiology of invasive fungal infections in neonates and children
   William J. Steinbach · 2010 · Clinical Microbiology and Infection
6. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
   Ana Espinel‐Ingroff, Maximiliano Álvarez-Fernández, Rafael Cantón, Peggy L. Carver, S. C.- A. Chen, Gregory A. Eschenauer, Diane Getsinger, Gloria María González, Nelesh Premapragasan Govender, Anna Grancini et al. · 2015 · Antimicrobial Agents and Chemotherapy
7. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
   Susana Beatriz Córdoba, Walter Vivot, María Eugenia Bosco‐Borgeat, Constanza Giselle Taverna, Wanda Szusz, Omar Alejandro Murisengo, Guillermina Isla, Graciela Davel · 2011 · PubMed
8. Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods
   Suhail Ahmad, Z. U. Khan · 2012 · Indian Journal of Medical Microbiology
9. Epidemiology and predictors of a poor outcome in elderly patients with candidemia
   Thaís Guimarães, Márcio Nucci, João Silva de Mendonça, Roberto Martínez, Ligia R. Brito, Nivia Silva, Maria Luíza Moretti, Reinaldo Salomão, Arnaldo Lopes Colombo · 2012 · International Journal of Infectious Diseases
10. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms
    Raul Leal Faria Luiz, Taissa Vieira Machado Vila, João Carlos Palazzo de Mello, Celso Vataru Nakamura, Sônia Rozental, Kelly Ishida · 2015 · BMC Complementary and Alternative Medicine
11. Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
    Ping Liu, Markus Ruhnke, Wouter Meersseman, José Artur Paiva, Michal Kantecki, Bharat D. Damle · 2013 · Antimicrobial Agents and Chemotherapy
12. Impact of Education and an Antifungal Stewardship Program for Candidiasis at a Thai Tertiary Care Center
    Anucha Apisarnthanarak, Apiwat Yatrasert, Linda M. Mundy · 2010 · Infection Control and Hospital Epidemiology
13. Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study
    E. Ghrenassia, Djamel Mokart, Julien Mayaux, Alexandre Demoule, I. Rezine, Lionel Kerhuel, Laure Calvet, Audrey DE JONG, Élie Azoulay, Michaël Darmon · 2019 · Annals of Intensive Care
14. Fungal Endocarditis
    Shi-Min Yuan · 2016 · Brazilian Journal of Cardiovascular Surgery
15. Challenging issues in neonatal candidiasis
    David A Kaufman · 2010 · Current Medical Research and Opinion
16. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections
    Emily L. Heil, Lindsay M. Daniels, Dustin Marsh Long, Kyle G. Rodino, David J. Weber, Melissa B. Miller · 2012 · American Journal of Health-System Pharmacy
17. Empiric Antifungal Therapy and Outcomes in Extremely Low Birth Weight Infants with Invasive Candidiasis
    Rachel G. Greenberg, Daniel K. Benjamin, Marie G. Gantz, Charles Michael Cotten, Barbara J. Stoll, Michele C. Walsh, Pablo J. Sánchez, Seetha Shankaran, Abhik Das, Rosemary D. Higgins et al. · 2012 · The Journal of Pediatrics
18. Candida Urinary Tract Infections—Epidemiology, Pathogenesis, Diagnosis, and Treatment: Executive Summary
    John F. Fisher · 2011 · Clinical Infectious Diseases
19. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures
    Youcef Megri, Amir A. Arastehfar, Teun Boekhout, Farnaz Daneshnia, Caroline Hörtnagl, Bettina Sartori, Ahmed Ibrahem Hafez, Weihua Pan, Cornelia Lass‐Flörl, B Hamrioui · 2020 · Antimicrobial Resistance and Infection Control
20. Are the Statins promising antifungal agents against invasive candidiasis?
    Lima, William Gustavo, Alves-Nascimento, Lídia Anita, Andrade, Jéssica Tauany, Vieira, Letícia, de Azambuja Ribeiro, Rosy Iara Maciel, Thomé, Ralph Gruppi, dos Santos, Hélio Batista, Ferreira, Jaqueline Maria Siqueira, Soares, Adriana Cristina · 2019 · Biomedicine &amp; Pharmacotherapy
21. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum
    Shields, Ryan K., Nguyen, M. Hong, Du, Chen, Press, Ellen, Cheng, Shaoji, Clancy, Cornelius J. · 2011 · Antimicrobial Agents and Chemotherapy
22. Strategies to Prevent Invasive Candidal Infection in Extremely Preterm Infants
    David A Kaufman, Paolo Manzoni · 2010 · Clinics in Perinatology
23. Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience
    Ryuichi Hirano, Yuichi Sakamoto, Kumiko Kudo, Motoki Ohnishi · 2015 · Infection and Drug Resistance
24. Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets
    Kashyap Patel, Jason Alexander Roberts, Jeffrey Lipman, Susan E. Tett, Megan Deldot, Carl M. J. Kirkpatrick · 2011 · Antimicrobial Agents and Chemotherapy
25. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs
    J.-F. Wang, Yitao Xue, X.-B. Zhu, Hui Zhen Fan · 2014 · European Journal of Clinical Microbiology & Infectious Diseases
26. Combination ofCandidabiomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment
    María del Carmen Martínez‐Jiménez, Patricia Muñóz, Maricela Valerio, Antonio Vena, Jesús Guinea, Emilio Bouza · 2015 · Journal of Antimicrobial Chemotherapy
27. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
    Sébastien Bailly, Olivier Leroy, Philippe Montravers, Jean‐Michel Constantin, Hervé Dupont, Didier Guillemot, Olivier Lortholary, Jean Paul Mira, Pierre-François Pérrigault, Jean‐Pierre Gangneux et al. · 2015 · Intensive Care Medicine
28. Safety of fluconazole in paediatrics: a systematic review
    Oluwaseun Egunsola, Abiodun Adefurin, Apostolos Fakis, Évelyne Jacqz-Aigrain, Imti Choonara, Helen Mary Sammons · 2013 · European Journal of Clinical Pharmacology
29. In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis , C. orthopsilosis , and C. parapsilosis Evaluated by Time-Kill Studies
    Emilia Cantón, Ana Espinel‐Ingroff, Javier Pemán, Lucas del Castillo · 2010 · Antimicrobial Agents and Chemotherapy
30. Isavuconazole Pharmacodynamic Target Determination for Candida Species in an In Vivo Murine Disseminated Candidiasis Model
    Alexander J. Lepak, Karen Marchillo, Jamie VanHecker, Daniel J. Diekema, David R. Andes · 2013 · Antimicrobial Agents and Chemotherapy
31. Antifungal Properties of Malaysian Tualang Honey and Stingless Bee Propolis against Candida albicans and Cryptococcus neoformans
    Aminu Shehu, Salwani Binti Ismail, Mohd Adzim Khalili Rohin, Azian Binti Harun, Aniza Aziz, Mainul Haque · 2016 · Journal of Applied Pharmaceutical Science
32. Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis
    Jiaying Fang, Bin Huang, Zan Ding · 2020 · Journal of Prosthetic Dentistry
33. Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
    Bizerra, Fernando César, Jimenez-Ortigosa, Cristina, Souza, Ana Carolina R., Breda, Giovanni Luis, Queiroz-Telles, Flávio, Perlin, David S., Colombo, Arnaldo L. · 2014 · Antimicrobial Agents and Chemotherapy
34. Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
    Arnaud Fekkar, Éric Dannaoui, I. Meyer, Sébastien Imbert, Jean‐Yves Brossas, Madalina Uzunov, Guillaume Mellon, Stéphanie Nguyen‐Quoc, Elsa Guiller, Éric Caumes et al. · 2014 · European Journal of Clinical Microbiology & Infectious Diseases
35. The Adaptor CARD9 Is Required for Adaptive but Not Innate Immunity to Oral Mucosal Candida albicans Infections
    Shrinivas Bishu, Nydiaris Hernández‐Santos, Michelle R. Simpson-Abelson, Anna R. Huppler, Heather R. Conti, Nico Ghilardi, Anna J. Mamo, Sarah L. Gaffen · 2013 · Infection and Immunity
36. Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species
    Carlos Cavaleiro, Lı́gia Salgueiro, Maria José Gonçalves, Karnjana Hrimpeng, Jéssica Pinto, Eugénia Pinto · 2015 · Journal of Natural Medicines
37. The value of amphotericin B in the treatment of invasive fungal infections
    Michael E. Klepser · 2010 · Journal of Critical Care
38. Invasive fungal infections in transplant recipients
    José A. Vázquez, Marisa H. Miceli, George John Alangaden · 2013 · Therapeutic Advances in Infectious Disease
39. Dried Blood Spot Analysis Suitable for Therapeutic Drug Monitoring of Voriconazole, Fluconazole, and Posaconazole
    Kim C. M. van der Elst, Lambert F. R. Span, Kai van Hateren, Karin Marianne Vermeulen, Tjip S. van der Werf, Ben Greijdanus, Jos G. W. Kosterink, Donald R. A. Uges, Jan‐Willem C. Alffenaar · 2013 · Antimicrobial Agents and Chemotherapy
40. Antifungal Prophylaxis in Liver Transplantation: A Systematic Review and Network Meta-Analysis
    Jennifer Evans, Peter J. Morris, Simon Robert Knight · 2014 · American Journal of Transplantation
41. Opportunistic fungal infections in the Asia-Pacific region
    Monica A. Slavin, Arunaloke Chakrabarti · 2012 · Medical Mycology
42. The role of antifungals against Candida biofilm in catheter-related candidemia
    Bouza, Emilio, Guinea, Jesús, Guembe, María · 2014 · Antibiotics
43. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking
    Zhao, Miao, Zhang, Fan, Zarnowski, Robert, Barns, Kenneth, Jones, Ryley, Fossen, Jen, Sanchez, Hiram, Rajski, Scott R., Audhya, Anjon, Bugni, Tim S. et al. · 2021 · Journal of Clinical Investigation
44. Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
    Lepak, Alexander, Andes, David · 2011 · Critical Care Clinics
45. Neonatal invasive candidiasis: updates on clinical management and prevention
    Ryan Kilpatrick, Evelyn R. Scarrow, Chi Hornik, Rachel G Greenberg · 2021 · The Lancet Child & Adolescent Health
46. Candida,Cryptococcus, and Other Yeasts of Medical Importance
    Susan A. Howell, Kevin C. Hazen, Mary E. Brandt · 2015 · ASM Press eBooks
47. Improving the management of candidemia through antimicrobial stewardship interventions
    Erica E. Reed, Jessica E. West, Ellen A. Keating, Preeti Pancholi, Joan-Miquel Balada-Llasat, Julie E. Mangino, Karri A A Bauer, Debra A. Goff · 2013 · Diagnostic Microbiology and Infectious Disease
48. Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation
    Kevin Watt, Daniel González, Daniel K. Benjamin, Kim L. R. Brouwer, Kelly Cant Wade, Edmund V. Capparelli, Jeffrey S. Barrett, Michael Cohen‐Wolkowiez · 2015 · Antimicrobial Agents and Chemotherapy
49. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
    Jeniel E. Nett, David R. Andes · 2015 · Microbiology Spectrum
50. Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
    Jessica Song, David A. Stevens · 2015 · Critical Reviews in Microbiology
51. Candida Arthritis: Analysis of 112 Pediatric and Adult Cases
    Maria N. Gamaletsou, Blandine Rammaert, Marimelle A. Bueno, Nikolaos V. Sipsas, Brad Moriyama, Dimitrios P. Kontoyiannis, Emmanuel Roilides, Valérie Zeller, Saad J. Taj‐Aldeen, Andy O. Miller et al. · 2015 · Open Forum Infectious Diseases
52. Candiduria: Evidence-based approach to management, are we there yet?
    Wadha Ahmed Alfouzan, Rita Dhar · 2017 · Journal de Mycologie Médicale
53. Infections in Patients with Cancer
    Lior Nesher, Kenneth V. I. Rolston · 2017 · Holland‐Frei Cancer Medicine
54. Reverse Genetics in Candida albicans Predicts ARF Cycling Is Essential for Drug Resistance and Virulence
    Epp, Elias, Vanier, Ghyslaine, Harcus, Doreen, Lee, Anna Y., Jansen, Gregor, Hallett, Michael, Sheppard, Don C., Thomas, David Y., Munro, Carol A., Mullick, Alaka et al. · 2010 · PLoS Pathogens
55. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India
    Chander, Jagdish, Singla, Nidhi, Sidhu, Shailpreet Kaur, Gombar, Satinder · 2013 · The Journal of Infection in Developing Countries
56. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates
    Eschenauer, Gregory A., Nguyen, M. Hong, Shoham, Shmuel, Vazquez, Jose A., Morris, Arthur J., Pasculle, William A., Kubin, Christine J., Klinker, Kenneth P., Carver, Peggy L., Hanson, Kimberly E. et al. · 2014 · Antimicrobial Agents and Chemotherapy
57. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients
    Vincent J. C. Lempers, Jeroen A. Schouten, Nicole Hunfeld, Angela P. H. Colbers, Henk J. van Leeuwen, David Marinus Burger, Paul E. Verweij, Peter Pickkers, Roger J. M. Brüggemann · 2015 · Antimicrobial Agents and Chemotherapy
58. Voriconazole in clinical practice
    Małgorzata Mikulska, Andrea Novelli, Franco Aversa, Simone Cesaro, Francesco Giuseppe De Rosa, Corrado Girmenia, Alessandra Micozzi, Maurizio Sanguinetti, Claudio Viscoli · 2012 · Journal of Chemotherapy
59. Fungal Infections in Transplant and Oncology Patients
    Anna K. Person, Dimitrios P. Kontoyiannis, Barbara Dudley Alexander · 2010 · Infectious Disease Clinics of North America
60. Diseases of the Mouth
    Hugh J. Silk · 2014 · Primary Care Clinics in Office Practice
61. Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
    Nathan P. Wiederhold, Laura K. Najvar, Rosie A. Bocanegra, William R. Kirkpatrick, Thomas F. Patterson · 2011 · Antimicrobial Agents and Chemotherapy
62. Successful Granulocyte Colony-stimulating Factor Treatment of Relapsing Candida albicans Meningoencephalitis Caused by CARD9 Deficiency
    Fatih Çelmeli, Nefise Öztoprak, Doğa Türkkahraman, Derya Seyman, Esvet Mutlu, Natalie Frede, Sadi Köksoy, Bodo Grimbacher · 2015 · The Pediatric Infectious Disease Journal
63. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
    Francesco Barchiesi, Elena Orsetti, Patrizia Osimani, Carlo Catassi, Fabio Santelli, Esther Manso · 2016 · BMC Infectious Diseases
64. Systemic Antifungal Agents: Current Status and Projected Future Developments
    Seyedmojtaba Seyedmousavi, Haleh Rafati, Macit İlkit, Ali Tolooe, Mohammad Taghi Hedayati, Paul E. Verweij · 2016 · Methods in molecular biology
65. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study
    Anna Candoni, Morena Caira, Simone Cesaro, Alessandro Busca, Mareva Giacchino, Rosa Fanci, Mario Delia, Annamaria Nosari, A Bonini, Chiara M. Cattaneo et al. · 2013 · Mycoses
66. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents
    Firas Choukri, M. Benderdouche, Patrice Sednaoui · 2014 · Journal de Mycologie Médicale
67. Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy
    Stefan Weiler, Christoph Seger, Hartwig Pfisterer, Eva Stienecke, Florian Stippler, René Welte, Michael Joannidis, Andrea Griesmacher, Romuald Bellmann · 2013 · Antimicrobial Agents and Chemotherapy
68. Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients
    Sébastien Bailly, Lila Bouadma, Élie Azoulay, Maïté Garrouste-Orgeas, Christophe Adrie, Bertrand Souweine, Carole Schwebel, Danièle Maubon, Rébecca Hamidfar-Roy, Michaël Darmon et al. · 2015 · American Journal of Respiratory and Critical Care Medicine
69. Outcomes Following Candiduria in Extremely Low Birth Weight Infants
    James Lawrence Wynn, Sylvia Tan, Marie G. Gantz, Abhik Das, Ronald N. Goldberg, Ira S. Adams-Chapman, Barbara J. Stoll, Seetha Shankaran, M. C. Walsh, Kathy J. Auten et al. · 2011 · Clinical Infectious Diseases
70. Nosocomial Infection in Adult Patients Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation
    Gwan Sic Kim, Kyo Seon Lee, Choung Kyu Park, Seung Ku Kang, Dowan Kim, Sang Gi Oh, Bong-Suk Oh, Yochun Jung, Seok Kim, Ju Sik Yun et al. · 2017 · Journal of Korean Medical Science
71. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates
    Jen‐Fu Hsu, Mei‐Yin Lai, Chiang‐Wen Lee, Shih‐Ming Chu, I-Hsyuan Wu, Hsuan‐Rong Huang, I‐Te Lee, Ming‐Chou Chiang, Ren-Huei Fu, Ming-Horng Tsai · 2018 · BMC Infectious Diseases
72. Infectious Disease Complications in Patients with Cancer
    Susan K. Seo, Catherine Liu, Sanjeet Dadwal · 2020 · Critical Care Clinics
73. Neonatal invasive fungal infection in England 2004–2010
    Clarissa Oeser, Stefania Vergnano, RD Naidoo, Madalaimuthu Anthony, Jiaqian Chang, Peter Chow, Paul Clarke, Nicholas David Embleton, Nigel L. Kennea, Santosh Pattnayak et al. · 2014 · Clinical Microbiology and Infection
74. Molecular Identification of Closely Related Candida Species Using Two Ribosomal Intergenic Spacer Fingerprinting Methods
    Muriel Cornet, Boualem Sendid, Chantal Fradin, Claude M. Gaillardin, Daniel Poulain, Huu-Vang Nguyen · 2011 · Journal of Molecular Diagnostics
75. The preanalytical optimization of blood cultures: a review and the clinical importance of benchmarking in 5 Belgian hospitals
    Elise Willems, Annick Smismans, Reinoud Cartuyvels, Guy Coppens, Kristien Van Vaerenbergh, Anne‐Marie Van den Abeele, Johan Frans · 2012 · Diagnostic Microbiology and Infectious Disease
76. Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin
    Michael A. Pfaller, Linda B. Boyken, Richard J. Hollis, Jennifer S. Kroeger, Shawn A. Messer, Shailesh Tendolkar, Daniel J. Diekema · 2010 · Journal of Clinical Microbiology
77. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues
    Maiken Cavling Arendrup, Brian T. Fisher, Theoklis E. Zaoutis · 2009 · Clinical Microbiology and Infection
78. Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia
    Dhara N. Shah, Raymond Ching Hin Yau, Todd Michael Lasco, Jaye S. Weston, Miguel J. Salazar, Hannah R. Palmer, Kevin W. Garey · 2012 · Antimicrobial Agents and Chemotherapy
79. Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis
    Charles R. Sims, Siraya Jaijakul, John Mohr, José E. Rodríguez, Malcolm Finkelman, Luis Ostrosky‐Zeichner · 2012 · Journal of Clinical Microbiology
80. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants
    Évelyne Jacqz-Aigrain, Stéphanie Leroux, Alison H. Thomson, Karel Allegaert, Edmund V. Capparelli, Valérie Biran, Nicolas Simon, Bernd Meibohm, Yoke Lin Lo, Remedios Marqués et al. · 2019 · Journal of Antimicrobial Chemotherapy
81. Procalcitonin levels in candidemia versus bacteremia: a systematic review
    Andrea Cortegiani, Giovanni Misseri, Mariachiara Ippolito, Matteo Bassetti, Antonino Giarratano, Ignacio Martín‐Loeches, Sharon Einav · 2019 · Critical Care
82. Rat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
    Nett, Jeniel E., Brooks, Erin G., Cabezas-Olcoz, Jonathan, Sanchez, Hiram, Zarnowski, Robert, Marchillo, Karen, Andes, David R. · 2014 · Infection and Immunity
83. The search for endocarditis in patients with candidemia: A systematic recommendation for echocardiography? A prospective cohort
    on behalf of the GAME Study Group (Grupo de Apoyo al Manejo de la Endocarditis), Fernández-Cruz, A., Cruz Menárguez, M., Muñoz, P., Pedromingo, M., Peláez, T., Solís, J., Rodríguez-Créixems, M., Bouza, E. · 2015 · European Journal of Clinical Microbiology &amp; Infectious Diseases
84. Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
    B. Dupont, Olivier Lortholary, Luis Ostrosky‐Zeichner, Flavie Stucker, Vijay V. Yeldandi · 2009 · Critical Care
85. Antimicrobial Effect of Thymus capitatus and Citrus limon var. pompia as Raw Extracts and Nanovesicles
    Roberto Pinna, Enrica Filigheddu, Claudia Juliano, Alessandra Palmieri, Maria Manconi, G D'Hallewin, Giacomo Luigi Petretto, Margherita Maioli, Carla Caddeo, María Letizia Manca et al. · 2019 · Pharmaceutics
86. Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
    Markus Ruhnke, José Artur Paiva, Wouter Meersseman, Jan Pachl, Ioana Grigoraș, Gabriele Sganga, Francesco Menichetti, Philippe Montravers, Georg M. Auzinger, G. Dimopoulos et al. · 2012 · Clinical Microbiology and Infection
87. Risk Factors Associated With Invasive Fungal Disease in Children With Cancer and Febrile Neutropenia
    Milena Villarroel C., Carmen Luz Avilés, Pamela Silva, Ana María Guzmán, Helena Poggi M, Ana Alvarez, Ana Becker, Miguel O’Ryan, Carmen Salgado, Santiago Topelberg V et al. · 2010 · The Pediatric Infectious Disease Journal
88. Performance of matrix‐assisted laser desorption‐time of flight mass spectrometry for identification of clinical yeast isolates
    Flemming Schønning Rosenvinge, Esad Dzajic, Elisa Knudsen, Sanne Malig, Line Bisgaard Andersen, Annette Løvig, Maiken Cavling Arendrup, Thøger Gorm Jensen, Bente Gahrn‐Hansen, Michael Kemp · 2012 · Mycoses
89. Candida Prosthetic Joint Infection. A Review of Treatment Methods
    Fernando Cobo, Javier Rodríguez‐Granger, Antonio Sampedro, Luis Aliaga–Martínez, José María Navarro‐Marí · 2017 · Journal of Bone and Joint Infection
90. Delivery of biologics: Topical administration
    Rachel J. Kulchar, RAHUL KUMAR SINGH, Suwan Ding, Elena Alexander, Kam W. Leong, Henry Daniell · 2023 · Biomaterials
91. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi‐centre study
    A. Schmalreck, Birgit Willinger, Gerhard Haase, Gerhard Blum, Cornelia Lass‐Flörl, W. Fegeler, Karsten Becker, for the Antifungal Susceptibility Testing (AFST) Study Group · 2012 · Mycoses
92. Azole‐resistant Candida spp. – emerging pathogens?
    Selma Tobudic, Christina Kratzer, Elisabeth Presterl · 2012 · Mycoses
93. Traditional and Emerging Antifungal Therapies
    Tamra M. Arnold, Emily K. Dotson, George A. Sarosi, Chadi A. Hage · 2010 · Proceedings of the American Thoracic Society
94. Multicenter surveillance of species distribution and antifungal susceptibilities ofCandidabloodstream isolates in South Korea
    Sook‐In Jung, Jong Hee Shin, Jae‐Hoon Song, Kyong Ran Peck, Kyungwon Lee, Mi‐Na Kim, Hyun‐Ha Chang, Chi Sook Moon · 2010 · Medical Mycology
95. Review of the New Delayed‐Release Oral Tablet and Intravenous Dosage Forms of Posaconazole
    Anthony J. Guarascio, Douglas Slain · 2015 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
96. Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
    Matteo Bassetti, Małgorzata Mikulska, Claudio Viscoli · 2010 · Critical Care
97. Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: A systematic review.
    Sinnollareddy, Mahipal, Peake, Sandra L., Roberts, Michael S., Lipman, Jeffrey, Roberts, Jason A. · 2012 · International Journal of Antimicrobial Agents
98. Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study
    Tafireyi Marukutira, Shirish S. Huprikar, Nkechi E. Azie, Shun-Ping Quan, Ulf Meier‐Kriesche, David Horn · 2014 · HIV/AIDS - Research and Palliative Care
99. The echinocandins: three useful choices or three too many?
    Abhijit M. Bal · 2009 · International Journal of Antimicrobial Agents
100. Invasive Fungal Infections in Children
     Hans Jürgen Dornbusch, Paolo Manzoni, Emmanuel Roilides, Thomas J. Walsh, Andreas H. Groll · 2009 · The Pediatric Infectious Disease Journal